Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Sobre Lite Strategy

Fundada

2018

Comunidade

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Detalhes da arrecadação de fundos

Rodada de financiamentoQuantiaValorização
Date
Investidores
Post-IPO
R$543.16M
--
2025-07-21
--